Simplified clinical algorithm for identifying patients eligible for same-day HIV treatment initiation (SLATE): Results from an individually randomized trial in South Africa and Kenya

English version

Autoři: Sydney Rosen ^aff001; Mhairi Maskew ^aff002; Bruce A. Larson ^aff001; Alana T. Brennan ^aff001; Isaac Tsikhutsu ^aff004; Matthew P. Fox ^aff001; Lungisile Vezi ^aff002; Margaret Bii ^aff004; Willem D. F. Venter ^aff006
Působiště autorů: Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, United States of America ^aff001; Health Economics and Epidemiology Research Office, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa ^aff002; Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts, United States of America ^aff003; Kenya Medical Research Institute, Kericho, Kenya ^aff004; Henry M. Jackson Foundation Medical Research International, Inc., Nairobi, Kenya ^aff005; Ezintsha, Wits Reproductive Health and HIV Institute, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa ^aff006
Vyšlo v časopise: Simplified clinical algorithm for identifying patients eligible for same-day HIV treatment initiation (SLATE): Results from an individually randomized trial in South Africa and Kenya. PLoS Med 16(9): e32767. doi:10.1371/journal.pmed.1002912
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1002912

Souhrn

Background

The World Health Organization recommends "same-day" initiation of antiretroviral therapy (ART) for HIV patients who are eligible and ready. Identifying efficient, safe, and feasible procedures for determining same-day eligibility and readiness is now a priority. The Simplified Algorithm for Treatment Eligibility (SLATE) study evaluated a clinical algorithm that allows healthcare workers to determine eligibility for same-day treatment and to initiate ART at the patient’s first clinic visit.

Methods and findings

SLATE was an individually randomized trial at three outpatient clinics in urban settlements in Johannesburg, South Africa and three hospital clinics in western Kenya. Adult, nonpregnant, HIV-positive, ambulatory patients presenting for any HIV care, including HIV testing, but not yet on ART were enrolled and randomized to the SLATE algorithm arm or standard care. The SLATE algorithm used four screening tools—a symptom self-report, medical history questionnaire, physical examination, and readiness assessment—to ascertain eligibility for same-day initiation or refer for further care. Follow-up was by record review, and analysis was conducted by country. We report primary outcomes of 1) ART initiation ≤28 days and 2) initiation ≤28 days and retention in care ≤8 months of enrollment. From March 7, 2017 to April 17, 2018, we enrolled 600 patients (median [IQR] age 34 [29–40] and CD4 count 286 [128–490]; 63% female) in South Africa and 477 patients in Kenya (median [IQR] age 35 [29–43] and CD4 count 283 [117–541]; 58% female). In the intervention arm, 78% of patients initiated ≤28 days in South Africa, compared to 68% in the standard arm (risk difference [RD] [95% confidence interval (CI)] 10% [3%–17%]); in Kenya, 94% of intervention-arm patients initiated ≤28 days compared to 89% in the standard arm (6% [0.5%–11%]). By 8 months in South Africa, 161/298 (54%) intervention-arm patients had initiated and were retained, compared to 146/302 (48%) in the standard arm (6% [(2% to 14%]). By 8 months in Kenya, the corresponding retention outcomes were identical in both arms (137/240 [57%] of intervention-arm patients and 136/237 [57%] of standard-arm patients). Limitations of the trial included limited geographic representativeness, exclusion of patients too ill to participate, missing viral load data, greater study fidelity to the algorithm than might be achieved in standard care, and secular changes in standard care over the course of the study.

Conclusions

In South Africa, the SLATE algorithm increased uptake of ART within 28 days by 10% and showed a numerical increase (6%) in retention at 8 months. In Kenya, the algorithm increased uptake of ART within 28 days by 6% but found no difference in retention at 8 months. Eight-month retention was poor in both arms and both countries. These results suggest that a simple structured algorithm for same-day treatment initiation procedures is feasible and can increase and accelerate ART uptake but that early retention on treatment remains problematic.

Trial registration

Clinicaltrials.gov NCT02891135, registered September 1, 2016. First participant enrolled March 6, 2017 in South Africa and July 13, 2017 in Kenya.

Klíčová slova:

Biology and life sciences – Organisms – Physical sciences – Research and analysis methods – People and places – Mathematics – Simulation and modeling – Geographical locations – Medicine and health sciences – Microbiology – Medical microbiology – Microbial pathogens – Pathology and laboratory medicine – Pathogens – Diagnostic medicine – Africa – South Africa – Infectious diseases – Bacterial diseases – Tuberculosis – Tropical diseases – Viral pathogens – Immunodeficiency viruses – HIV – Retroviruses – Lentivirus – Viruses – RNA viruses – Immunology – Vaccination and immunization – Public and occupational health – Preventive medicine – Antiviral therapy – Virology – Viral transmission and infection – Viral load – HIV diagnosis and management – Kenya – Applied mathematics – Algorithms

Zdroje

1. World Health Organization. Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy. Geneva: World Health Organization; 2017. Available from: http://www.who.int/hiv/pub/guidelines/advanced-HIV-disease/en/.

2. National Department of Health. Same-day antiretroviral therapy (ART) initiation for HIV positive patients. Pretoria: National Department of Health; 2017.

3. Ministry of Health and National AIDS and STI Control Program (NASCOP). Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection in Kenya 2018 Edition. Nairobi, Kenya: NASCOP; 2018.

4. Rosen S, Maskew M, Fox MP, Nyoni C, Mongwenyana C, Malete G, et al. Initiating antiretroviral therapy for HIV at a patient’s first clinic visit: the RapIT randomized controlled trial. PLoS Med. 2016;13: e1002015. doi: 10.1371/journal.pmed.1002015 27163694

5. Long LC, Maskew M, Brennan AT, Mongwenyana C, Nyoni C, Malete G, et al. Initiating antiretroviral therapy for HIV at a patient’s first clinic visit: a cost-effectiveness analysis of the rapid initiation of treatment randomized controlled trial. AIDS. 2017;31: 1611–19. doi: 10.1097/QAD.0000000000001528 28463879

6. Rosen S, Fox MP, Larson B, Sow PS, Ehrenkranz PD, Venter F, et al. Accelerating the uptake and timing of antiretroviral therapy initiation in sub-Saharan Africa: an operations research agenda. PLoS Med. 2016;13: e1002106. doi: 10.1371/journal.pmed.1002106 27505444

7. Rosen S, Fox MP, Larson BA, Brennan AT, Maskew M, Tsikhutsu I, et al. Simplified clinical algorithm for identifying patients eligible for immediate initiation of antiretroviral therapy for HIV (SLATE): protocol for a randomized evaluation. BMJ Open. 2017;7: e016340. doi: 10.1136/bmjopen-2017-016340 28554939

8. National Department of Health. National consolidated guidelines for the prevention of mother-to-child transmission of HIV (PMTCT) and the management of HIV in children, adolescents, and adults. Pretoria: National Department of Health, Republic of South Africa; 2015. Available from: http://www.sahivsoc.org/Files/ART%20Guidelines%2015052015.pdf.

9. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42: 377–381. doi: 10.1016/j.jbi.2008.08.010 18929686

10. National Department of Health. Evaluation of the National Adherence Guidelines for Chronic Diseases in South Africa: patient perspectives on differentiated care models. Washington, DC: The World Bank; 2017. Available from: http://hdl.handle.net/10986/28874.

11. National Department of Health. Evaluation of the National Adherence Guidelines for Chronic Diseases in South Africa: the impact of differentiated care models on short-term indicators in HIV patients. Washington, DC: The World Bank, 2017. Available from: https://openknowledge.worldbank.org/handle/10986/29396.

12. National Department of Health. Implementation of the universal test and treat strategy for HIV positive patients and differentiated care for stable patients. Pretoria: National Department of Health, Republic of South Africa; 2016.

13. Ministry of Health and National AIDS & STI Control Programme. Guidelines on Use of Antiretroviral Drugs For Treating and Preventing HIV Infection in Kenya 2016. Nairobi: NASCOP; 2016.

14. UNAIDS. Communities at the centre. Global AIDS Update 2019. Geneva: UNAIDS; 2019. Available from: https://www.unaids.org/en/resources/documents/2019/2019-global-AIDS-update.

15. Dorrington RE, Johnson LF. Modelling the impact of HIV in South Africa’ s provinces: 2017 update. Cape Town: Centre for Infectious Disease Epidemiology and Research, University of Cape Town; 2017. Available from: https://www.thembisa.org/content/filedl/Provinces2017.

16. Johnson L. South Africa’s HIV treatment programme: a phoenix rising from the ashes? GroundUp [Internet]. 2017 Dec 13 [cited 2018 Jul 13]. Available from: https://www.groundup.org.za/article/south-africas-hiv-treatment-programme-phoenix-rising-ashes/.

17. Olney JJ, Braitstein P, Eaton JW, Sang E, Nyambura M, Kimaiyo S, et al. Evaluating strategies to improve HIV care outcomes in Kenya: a modelling study. Lancet HIV. 2016;3: e592–e600. doi: 10.1016/S2352-3018(16)30120-5 27771231

18. Ahmed S, Autrey J, Katz IT, Fox MP, Rosen S, Onoya D, et al. Why do people living with HIV not initiate treatment? A systematic review of qualitative evidence from low- and middle-income countries. Soc Sci Med.2018; 213:72–84. doi: 10.1016/j.socscimed.2018.05.048 30059900

19. Ford N, Migone C, Calmy A, Kerschberger B, Kanters S, Nsanzimana S, et al. Benefits and risks of rapid initiation of antiretroviral therapy. AIDS 2018; 32:17–23. doi: 10.1097/QAD.0000000000001671 29112073

20. Amanyire G, Semitala FC, Namusobya J, Katuramu R, Kampiire L, Wallenta J, et al. Effects of a multicomponent intervention to streamline initiation of antiretroviral therapy in Africa: a stepped-wedge cluster-randomized trial. Lancet HIV 2016; 3:e539–e548. doi: 10.1016/S2352-3018(16)30090-X 27658873

21. Koenig SP, Dorvil N, De JG, Riviere C, Faustin M, Lavoile K, et al. Same-day HIV testing with initiation of antiretroviral therapy versus standard care for persons living with HIV: A randomized unblinded trial. PLoS Med. 2017;14: e1002357. doi: 10.1371/journal.pmed.1002357 28742880

22. Labhardt ND, Ringera I, Lejone TI, Klimkait T, Muhairwe J, Amstutz A, et al. Effect of offering same-day ART vs usual health facility referral during home-based HIV testing on linkage to care and viral suppression among adults with HIV in Lesotho: The CASCADE randomized clinical trial. JAMA 2018;319: 1103–1112. doi: 10.1001/jama.2018.1818 29509839

23. Onoya D, Sineke T, Hendrickson C, Maskew M, Long L, Fox M. Impact of universal test and treat and same-day treatment initiation policies on ART initiation among HIV positive patients in Johannesburg, South Africa. AIDS 2018, July 23–27, 2018, Amsterdam. Available from: https://programme.aids2018.org//PAGMaterial/eposters/11514.pdf.

24. Fox MP. Are we shifting attrition downstream in the HIV cascade? Lancet HIV 2016; 3: e554–5. doi: 10.1016/S2352-3018(16)30149-7 27771232